Hang Sun

Dr. Hang Sun

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Breast Cancer: Targets and Therapy
Verified
Journal Article
Open access
PDF file
XYXianwei Yang
Xianwei Yang
JLJing Li
Jing Li
HSHang Sun
Hang Sun
JCJing Chen
Jing Chen
JXJin Xie
Jin Xie
TPTongyong Pan
Tongyong Pan
Background: Accurate identification of the molecular subtypes of breast cancer is essential for effective treatment selection and prognosis prediction. Aim: This study aimed to evaluate the diagnostic performance of a radiomics model, which integrates breast mammography and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting the molecular subtypes of breast cancer. Methods: We retrospectively included 462 female patients with pathologically confirmed breast cancer, including 53 cases of triple-negative, 94 cases of HER2 overexpression, 95 cases of luminal A, and 215 cases of luminal B breast cancer. Radiomics analysis was performed using FAE software, wherein the radiomic features were examined about the hormone receptor status. The performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC) and accuracy. Results: In multivariate analysis, radiomic features were the only independent predictive factors for molecular subtypes. The model that incorporates multimodal fusion features from breast mammography and DCE-MRI images exhibited superior overall performance compared to using either modality independently. The AUC values (or accuracies) for six pairings were as follows: 0.648 (0.627) for luminal A vs luminal B, 0.819 (0.793) for luminal A vs HER2 overexpression, 0.725 (0.696) for luminal A vs triple-negative subtype, 0.644 (0.560) for luminal B vs HER2 overexpression, 0.625 (0.636) for luminal B vs triple-negative subtype, and 0.598 (0.500) for triple-negative subtype vs HER2 overexpression. Conclusion: The radionics model utilizing multimodal fusion features from breast mammography combined with DCE-MRI images showed high performance in distinguishing molecular subtypes of breast cancer. It is of significance to accurately predict prognosis and determine treatment strategy of breast cancer by molecular classification.

24 October 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
HSHang Sun
Hang Sun
HZHongjie Zhu
Hongjie Zhu
MZMenghan Zhang
Menghan Zhang
HLHong Li
Hong Li
XSXinran Shao
Xinran Shao
JCJianchun Cui
Jianchun Cui
Introduction: Breast tumors, predominantly benign, are a global health concern affecting women. Vacuum-assisted biopsysystems (VABB) guided by ultrasound are widely used forminimally invasive resection, but their reliance on surgeon experience and positioning challenges hinder adoption in primary healthcare settings. Existing AI solutions often focus on static ultrasound image analysis, failing to meet real-time surgical demands. Methods: This study presents a real-time positioning system for breast tumor rotational resection based on an optimized YOLOv11n architecture to enhance surgical navigation accuracy. Ultrasound video data from 167 patients (116 for training, 33 for validation, and 18 for testing) were collected to train the model. The model’s architecture was optimized across three major components: backbone, neck, and detection head. Key innovations include integrating MobileNetV4 Inverted Residual Block and MobileNetV4 Universal Inverted Bottleneck Block to reduce model parameters and computational load while improving inference efficiency. Results: Compared with the baseline YOLOv11n, the optimized YOLOv11n+ model achieves a 17.1% reduction in parameters and a 27.0% reduction in FLOPS, increasing mAP50 for cutter slot and tumor detection by 2.1%. Two clinical positioning algorithms (Surgical Method 1 and Surgical Method 2) were developed to accommodate diverse surgical workflows. The system comprises a deep neural network for target recognition and a real-time visualization module, enabling millisecond-level tracking, precise annotation, and intelligent prompts for optimal resection timing. Conclusion: These research findings provide technical support for minimally invasive breast tumor resection, holding the promise of reducing reliance on surgical experience and thereby facilitating the application of this technique in primary healthcare institutions.

13 November 2025 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
XSXinran Shao
Xinran Shao
YSYunzhi Shen
Yunzhi Shen
PSPingdong Sun
Pingdong Sun
YSYihan Sun
Yihan Sun
XJXingai Ju
Xingai Ju
JCJianchun Cui
Jianchun Cui
Vacuum-assisted breast biopsy (VABB) is a widely adopted minimally invasive technique for the diagnosis and treatment of breast lesions. However, the procedure heavily relies on real-time ultrasound guidance, posing significant challenges for junior surgeon who lack radiological experience in accurately localizing both the lesion and the biopsy needle. Currently, there is no dedicated real-time artificital intelligence (AI) navigation system specifically designed for VABB procedures. We developed a novel two-stage real-time AI navigation system based on the YOLOv11 deep learning architecture. Model 1 performs initial localization of the tumor and the cutter slot, while Model 2 focuses on real-time tracking of the knife and tumor during resection. The system was trained and validated using 22,278 annotated ultrasound images from 167 VABB procedures conducted at People's Hospital of China Medical University. A rigorous three-fold cross-validation was implemented to assess model performance, and the localization accuracy was compared with that of junior surgeon. Additionally, we evaluated the system’s real-time processing performance on both GPU and CPU platforms. The AI system demonstrated superior performance across all evaluated metrics. ForModel 1, the mean Average Precision at IoU threshold 0.5 (mAP50) for tumor detection and groove localization reached 0.907 and 0.671, respectively, significantly outperforming junior surgeon (0.551 and 0.120). For Model 2, the mAP50 for tumor and needle tip tracking were 0.829 and 0.765, respectively, compared to 0.758 and 0.350 achieved by surgeons. The system achieved a real-time processing speed of 1.2 ms per frame on GPU and 32.6 ms per frame on CPU. This study presents the first dedicated AI-based navigation system for VABB, showing substantial improvement in localization accuracy over manual operation by junior surgeon. The system’s robust detection capability and real-time performance highlight its strong potential for clinical application, especially in surgical training and complex cases requiring precise instrument control. Clinical Trial Registration No. 2022JH2/101300026